Echovirus Infections

Subscribe to Selected New Research on Echovirus Infections

17 relevant articles (0 outcomes, 1 trials/studies) found for this Disease

Description: Infectious disease processes, including meningitis, diarrhea, and respiratory disorders, caused by echoviruses.

Also Known As:

Echo Virus Infections; Infections, Echo Virus; Infections, Echovirus; Echo Virus Infection; Echovirus Infection; Infection, Echo Virus; Infection, Echovirus

Disease Context: Research Results

Virus Diseases: 1311

RNA Virus Infections: 36

Picornaviridae Infections: 38

Enterovirus Infections: 156

Echovirus Infections: 17

Related Diseases

1.	Rhabdomyosarcoma
2.	Infection
3.	Multiple Myeloma
4.	Enterovirus Infections

Experts

1.	Song, Li: 1 article (03/2002)
2.	Liu, Min: 1 article (03/2002)
3.	Su, Zheng: 1 article (03/2002)
4.	Li, Xiaomian: 1 article (03/2002)
5.	Meng, Yingtao: 1 article (03/2002)
6.	Goodfellow, I G: 1 article (05/2000)
7.	Ward, T: 1 article (05/2000)
8.	Powell, R M: 1 article (05/2000)
9.	Almond, J W: 1 article (05/2000)
10.	Evans, D J: 1 article (05/2000)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Echovirus Infections:

1.	LactoferrinIBA 02/01/2006 - "In the present study, we have investigated both the role of tryptic fragments of bovine lactoferrin and the mechanism of lactoferrin effect on echovirus infection" 03/01/2007 - "Recently, we have shown that bovine lactoferrin prevents the early phases of echovirus infection and also acts as a survival factor inhibiting viral-induced apoptosis" Order ALL the reference details at left...
2.	Complement System Proteins (Complement)IBA 05/01/1961 - "Observations on the complement-fixing antibody response to poliovirus in patients with certain Coxsackie and ECHO virus infections." 05/01/2000 - "Echovirus infection of rhabdomyosarcoma cells is inhibited by antiserum to the complement control protein CD59." 06/01/1989 - "Disseminated echovirus infection in a patient with multiple myeloma and a functional defect in complement" Order ALL the reference details at left...
3.	AntibodiesIBA 01/01/1993 - "The epidemiologic features of type 22 echovirus infections with regard to age and seasonal distribution, contagiousness and a relative lack of protection by neutralizing antibodies differed from most enterovirus infections." 03/01/2002 - "Establishment of an indirect enzyme-linked immunosorbent assay for detecting the specific IgM antibodies in patients with echovirus infection]" Order ALL the reference details at left...
4.	Integrin beta3 (GPIIIa)IBA 09/01/1999 - "Since E9/Barty does not replicate or replicates only poorly in mice older than about 5 days, and expression of the vitronectin receptor is reported to be down-regulated in striated muscle tissue during development, it is suggested that susceptibility of mice to this echovirus infection is controlled by the availability of alpha(v)beta3 integrin." Order ALL the reference details at left...
5.	Integrin alphaVbeta3IBA 09/01/1999 - "Since E9/Barty does not replicate or replicates only poorly in mice older than about 5 days, and expression of the vitronectin receptor is reported to be down-regulated in striated muscle tissue during development, it is suggested that susceptibility of mice to this echovirus infection is controlled by the availability of alpha(v)beta3 integrin." Order ALL the reference details at left...
6.	Integrin alpha2beta1IBA 09/01/1997 - "Persistent echovirus infection of mouse cells expressing the viral receptor VLA-2." Order ALL the reference details at left...
7.	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/01/1989 - "In addition, there was evidence of lymphocyte activation following the development of echovirus infection (increase in HLA-DR expression and elevated serum IL-2 receptor levels) which resolved with clinical improvement" Order ALL the reference details at left...
8.	Protease Inhibitors (Protease Inhibitor)IBA 01/01/2006 - "Very little drug discovery research is being done to develop inhibitors for echovirus infections, probably due to the broad-spectrum inhibition exhibited by capsid binding agents and protease inhibitors discovered for treatment of other picornaviruses" Order ALL the reference details at left...
9.	Immunoglobulin M (IgM)IBA 03/01/2002 - "Establishment of an indirect enzyme-linked immunosorbent assay for detecting the specific IgM antibodies in patients with echovirus infection]" Order ALL the reference details at left...
10.	HLA-DR Antigens (HLA-DR)IBA 01/01/1989 - "In addition, there was evidence of lymphocyte activation following the development of echovirus infection (increase in HLA-DR expression and elevated serum IL-2 receptor levels) which resolved with clinical improvement" Order ALL the reference details at left...

Therapies and Procedures

Bone Marrow Transplantation (Transplantation, Bone Marrow)

11/01/1997 - "Disseminated echovirus infection after allogeneic bone marrow transplantation."
04/01/1990 - "Disseminated echovirus infection complicating bone marrow transplantation."
11/01/1997 - "Disseminated enteric human cytopathogenic orphan (echo) virus infection after allogeneic bone marrow transplantation has been reported once previously: a patient developed a fatal infection with the virus being isolated from brain, lung and heart"
Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Echovirus Infections

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 0 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>